What is a treatment option for ARDS or IRDS?

Oxygen therapy is an essential treatment option for both Acute Respiratory Distress Syndrome (ARDS) and Infant Respiratory Distress Syndrome (IRDS). These conditions result in significant hypoxemia due to impaired gas exchange in the lungs. Oxygen therapy directly addresses the lack of oxygen in the blood, improving oxygen saturation levels and providing the necessary support for the patient’s respiratory function.

In ARDS, the lung inflammation can lead to fluid accumulation in the alveoli, impairing alveolar-capillary diffusion. By administering supplemental oxygen, healthcare providers aim to enhance oxygen delivery to tissues while minimizing the impact of lung injury. In the case of IRDS, which primarily affects premature infants, oxygen therapy is crucial in supporting their immature lungs that may be unable to provide adequate oxygenation on their own.

Other treatment options, while important in specific scenarios, do not directly address the immediate need for oxygenation. Cough suppressants may be counterproductive in patients with respiratory distress, as coughing can help clear secretions. Chest physiotherapy may assist in mobilizing secretions but does not provide direct oxygenation support. Antibiotics are indicated if a bacterial infection is present, but they do not address the primary issues of hypoxemia caused by ARDS or IRDS.